Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash Flows from Operating Activities:
Net income	$ 3,790	$ 3,521	$ 3,072
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	2,156	1,798	1,633
Loss on impairments	40	161	357
Share-based compensation	143	125	123
Gains on disposals from businesses and long-lived assets, net	(247)	(431)	(66)
Deferred tax expense (benefit)	167	180	(64)
(Income) loss from equity method investments	(26)	108	17
Pension and other postretirement benefits net periodic benefit cost	21	34	31
Non-cash operating lease costs	292	262	293
Other items, net	3	14	68
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Accounts receivable, net	121	(122)	(164)
Inventories	(161)	(224)	(60)
Accounts payable	(158)	48	144
Operating lease liabilities	(310)	(287)	(276)
Other assets	(210)	(69)	25
Other liabilities	45	(86)	(72)
Pension and other postretirement benefits contributions	(41)	(43)	(44)
Net cash provided by operating activities	5,625	4,989	5,017
Cash Flows from Investing Activities:
Purchases of property, plant and equipment, and intangibles	(2,713)	(2,578)	(1,817)
Acquisitions, net of cash acquired	(3,856)	(4,900)	(640)
Proceeds from divestitures	139	1,001	0
Proceeds from disposal of long-lived assets	315	272	104
Dividends received from equity method investments	50	44	44
Settlements of derivatives	(81)	(9)	(1)
Deferred divestiture consideration received	42	83	6
Other investing activities, net	59	(204)	(87)
Net cash used in investing activities	(6,045)	(6,291)	(2,391)
Cash Flows from Financing Activities:
Proceeds from debt issuances	10,479	4,001	3,163
Payments on debt	(7,612)	(1,859)	(1,462)
Settlements of derivatives	121	(36)	7
Payments of finance lease obligations	(131)	(57)	(26)
Deferred and contingent acquisition consideration paid	(31)	(21)	(22)
Dividends paid	(996)	(1,706)	(940)
Distributions to noncontrolling and redeemable noncontrolling interests	(34)	(53)	(35)
Transactions involving noncontrolling interests	28	19	(2)
Repurchases of common stock	(1,181)	(1,482)	(3,067)
Amounts related to employee share plans	(47)	8	4
Net cash provided by (used in) financing activities	596	(1,186)	(2,380)
Effect of exchange rate changes on cash and cash equivalents, including restricted cash	212	(143)	208
Increase (decrease) in cash and cash equivalents, including restricted cash	388	(2,631)	454
Cash and cash equivalents and restricted cash at the beginning of year	3,759	6,390	5,936
Cash and cash equivalents and restricted cash at the end of year	4,147	3,759	6,390
Supplemental cash flow information:
Cash paid for interest (including finance leases)	724	599	418
Cash paid for income taxes	831	960	959
Reconciliation of cash and cash equivalents and restricted cash
Cash and cash equivalents presented in the Consolidated Balance Sheets	4,096	3,720	6,341
Restricted cash presented in the Consolidated Balance Sheets	51	39	0
Cash and cash equivalents included in Assets held for sale	0	0	49
Total cash and cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows	$ 4,147	$ 3,759	$ 6,390